A founder’s introductionLet’s talk Membership medicine for movement health
A physical therapist who knows you. A plan that evolves with you. A clearer picture of your body.
GLP-1 · Postpartum · Pelvic health · Oncology
Use View controls to play the anatomy.
A postpartum journey through GLP-1 care.
One relationship. A changing body.
Strength, balance, and physical function deserve attention as the body changes.
The longer view
Function Health, Google Health, Apple Health, and wearables can deepen the picture. Alodaptive’s opportunity is to connect that context to clinical judgment, a visual explanation, and what someone does next.
A clinician who knows you.A plan you understand.A market already taking shape
Hinge Health demonstrates the scale of digital musculoskeletal care. Our opportunity: a continuing therapist relationship, with a visual companion that makes care understandable.
A complementary model of care
Counsel Health combines medical AI with physician-supervised messaging care. Alodaptive could complement it with therapist-led rehabilitation and a shared visual picture of progress.
Series A co-led by a16z and GV.
The addressable market
Begin alongside GLP-1 care. Expand the same clinical relationship across postpartum recovery, pelvic health, oncology, and other changes in physical function.
Total addressable market
GLP-1 entry market
104.5 million adults × $900 annually ≈ $94 billion.
The population estimate covers U.S. adults with movement-health needs associated with GLP-1 care, pregnancy and postpartum recovery, oncology, surgery, and aging. The calculation assumes $900 in annual care value per person.
31 million adults × $900 annually ≈ $28 billion.
The calculation uses an estimated U.S. GLP-1 population of 31 million and the same $900 annual care value per person. For population context, KFF’s November 2025 survey found that 12% of U.S. adults reported current GLP-1 use.
KFF · GLP-1 use survey
